UFlex Q4 FY26: Margin-Led Quarter as Big Projects Near Commissioning

UFlex closed Q4 FY26 with a clear improvement in operating momentum, even as management described FY26 as a challenging year for the packaging industry. Consolidated revenue for the quarter rose to Rs 40,973 million, up 12.8% sequentially and 5.7% year-on-year. The more meaningful change was in profitability. Consolidated EBITDA increased to Rs 6,265 million, and EBITDA margin expanded to 15.3%, up 260 bps QoQ and 300 bps YoY.

For the full year, UFlex delivered consolidated revenue of Rs 155,130 million, up 2.1% YoY. EBITDA rose 8.1% YoY to Rs 19,836 million, with margin at 12.8% versus 12.1% in FY25. Normalized EBITDA, however, was broadly flat YoY at Rs 19,097 million with a 12.3% margin, indicating that part of FY26’s reported improvement was supported by the swing in foreign currency and derivative line items.

What drove Q4 performance

The presentation attributes Q4 performance to a combination of higher volumes sequentially, better realizations across multiple product lines, and internal levers such as inventory optimization and product mix. Sales volumes in Q4 FY26 increased to 166,879 MT, up 10.3% QoQ and 1.0% YoY.

A key contributor appears to be improved spread conditions. The industry section notes that supply disruptions and raw material shortages created a favorable pricing environment, helping realizations and margin expansion across the packaging films and PET chip business. This was linked to disruptions in crude oil and petrochemical supply chains due to conflict in West Asia and constraints around the Strait of Hormuz.

On the demand side, the presentation points to a softer domestic consumption backdrop. India FMCG volume growth moderated to 0.9% in Q4 FY26. In aseptic liquid packaging, demand improved sequentially due to seasonality, but remained soft year-on-year amid moderate food and beverage consumption and pressure from duty-free imports.

Mix matters: Films still dominate, packaging is gaining

UFlex’s consolidated revenue mix underscores a business that remains film-led, but where packaging continues to increase its weight.

For FY26, business-wise revenue split was:

• Packaging films and polyester chips: 58.6%
• Packaging (flexible packaging, liquid packaging, holography): 32.7%
• Engineering: 2.9%
• Others VAP (including inks and adhesives and other operating income): 5.1%

Geographically, the origin-based mix for FY26 was:

• India: 47.0%
• Americas: 18.3%
• Europe: 17.2%
• Middle East and Africa: 14.6%
• Others: 2.1%

This split reflects the company’s global manufacturing footprint, which it positions as a resilience advantage in volatile supply chain conditions.

Note: Normalized EBITDA includes adjustments for foreign currency fluctuations and derivative gains or losses as described in the presentation.

Capacity utilization and the global footprint

UFlex continues to highlight operational reach across 9 countries. The presentation states 17 manufacturing facilities and an overall global capacity of 1.3 million plus MTPA, with a claim of being able to deliver anywhere within 15 days.

Packaging film production in Q4 FY26 was 126,076 tons per quarter, with overall utilization at 79.3% versus 74.3% in Q3 FY26. By geography, Q4 FY26 utilization ranged from mid-60% levels in India and Dubai to 93% in Egypt. The data also shows utilization above 100% in Hungary and USA.

The company also reported production volumes for packaging and chemicals, where Q4 FY26 utilization was 71.1% for liquid packaging, 80.2% for flexible packaging, and 51.7% for chemicals (inks and adhesives). This chemical utilization level is notable given that inks and adhesives are also positioned as a value-added part of the integrated portfolio.

Capex cycle: Near-term commissioning is the key catalyst

UFlex’s FY26 capex was Rs 20,425 million. In Q4 alone, capex spend was Rs 7,070 million, with major allocations toward Egypt aseptic packaging, Mexico WPP bags, the Noida recycling unit, and the Dharwad film project.

The capex update provides relatively clear milestones:

• Egypt aseptic packaging facility: planned annual capacity of 12 billion packs, targeted for commissioning in H1 FY27. Estimated project cost is about USD 126 million, with about USD 95.7 million already incurred.
• Dharwad BOPP line: a new 54,000 MTPA BOPP film manufacturing line with total capex of Rs 7,154 million. About Rs 785 million was incurred as of March 2026, and commissioning is expected in FY2027-28.
• Mexico WPP bags plant: an 80 million capacity woven polypropylene bag facility aimed at pet food packaging demand in the Americas. The project has incurred about USD 52 million and is in stability testing and validation batches before commissioning.

Management links these near-completion projects to capacity expansion, new revenue streams, and balance sheet deleveraging.

Sustainability and circularity: Recycling is now a core operating theme

The sustainability section ties the strategy to India’s Extended Producer Responsibility (EPR) framework under the Plastic Waste Management rules. The presentation includes year-wise targets for recycling and mandatory recycled content, and notes a proposed government update allowing a three-year carryforward of shortfall in meeting recycled-plastic content requirements for food-contact packaging for 2025-26.

Within this context, UFlex highlights Project Plastic Fix. It reports 586 million PCR PET bottles recycled in FY26 and 10,237 MT of PCR MLP waste recycled. It also positions product innovation such as ASCLEPIUS films made of 100% rPET chips.

The Chairman’s message adds that in early FY27, recycling facilities in Noida were commissioned with capacity to recycle nearly 40,000 MTPA of PET and mixed flexible waste.

Balance sheet: leverage remains elevated

The presentation discloses consolidated net debt of Rs 86,218 million as of March 2026. The leverage ratios shown are elevated, with net debt to EBITDA at 4.35x and net debt to normalized EBITDA at 4.51x based on annualized figures.

Gross debt increased to Rs 98,526 million at March 2026 from Rs 81,160 million at March 2025. The deck includes a statement that the Mexico WPP, Egypt aseptic, and Noida recycling projects are nearing completion and are expected to support deleveraging, but it does not quantify timelines for debt reduction.

Key takeaways

UFlex’s Q4 FY26 performance was driven by a strong sequential pick-up in volumes and realizations, translating into a meaningful EBITDA margin expansion. The company’s strategy remains centered on an integrated product suite and geographically diversified manufacturing.

The next phase is execution. Multiple large projects are either commissioned or nearing commissioning, including Noida recycling in early FY27, Egypt aseptic targeted for H1 FY27, and the larger Dharwad BOPP line scheduled for FY2027-28. With net debt at Rs 86,218 million and leverage above 4x on the company’s reported metrics, the pace at which these assets begin contributing to cash flows will be an important variable in how the story evolves.